TITLE

Qiagen makes a grab for Cellestis

PUB. DATE
April 2011
SOURCE
Australian Life Scientist;4/4/2011, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Cellestis board gives tick of approval to the deal which values the tuberculosis diagnostic company at $341.3 million.
ACCESSION #
59859921

 

Related Articles

  • Qiagen buys 61% of Ipsogen, beefs up its Cellestis offer.  // Medical Device Daily;7/12/2011, Vol. 15 Issue 128, p2 

    The article reports on the acquisition by Qiagen of 61% of Ipsogen, a developer of molecular profiling and personalized healthcare diagnostics for a wide range of applications in the hematology field.

  • Qiagen completes Digene buy; ME buys stroke treatment rights.  // Medical Device Daily;8/1/2007, Vol. 11 Issue 145, p2 

    The article reports on the completion of the acquisition of Digene by Qiagen of the Netherlands. Report says that Qiagen has completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of the company. Under the deal, Digene will become...

  • Qiagen's shareholders okay $1.6 billion merger with Digene.  // Medical Device Daily;7/23/2007, Vol. 11, p6 

    The article announced that Qiagen has received the vote of the necessary percentage of its shareholders in favor of the $1.6 billion acquisition of Digene at its extraordinary general meeting of shareholders held in the Netherlands. The companies reported that they had entered into a merger...

  • Rapigene bargain buy for Qiagen. Hodgson, John // Nature Biotechnology;Feb2000, Vol. 18 Issue 2, p132 

    Reports on the acquisition of the genomic analysis company Rapigene by the biotechnology company Qiagen NV. Factors which led to the acquisition of the genomic analysis company; Owner of Rapigene prior to the acquisition.

  • Qiagen now boasting extra Ingenuity after acquisition.  // Scientific Computing World;Jun/Jul2013, Issue 130, p4 

    The article reports on the acquisition of U.S.-based Ingenuity Systems Inc., provider of software solutions, by Qiagen NV, provider of sample and assay technologies.

  • Takeovers and stock price volatility. Lacker, Jeffrey M.; Weinberg, John A. // Economic Review (00946893);Mar/Apr90, Vol. 76 Issue 2, p29 

    Discusses takeovers and stock price volatility. Nature of the firm and the value of control; Description of the Martingale Model of stock prices; Empirical regularities in stock prices; Aggregate stock price movements; Corporate financial claims.

  • Average annual premiums over target stock prices.  // Mergers & Acquisitions: The Dealermaker's Journal;Jan/Feb94, Vol. 28 Issue 4, p56 

    Presents the average annual premiums over target stock prices of corporations undergoing consolidation and mergers from 1987 through September 1993. Number of deals; Number of deals with premiums; Premium four weeks and one day before deal announcement.

  • Average annual premiums over target stock prices in the 10 most active industries.  // Mergers & Acquisitions: The Dealermaker's Journal;Jan/Feb94, Vol. 28 Issue 4, p56 

    Presents the average annual premiums over target stock prices of the ten most active merger and acquisition industries in 1992. Number of deals; Number of deals with premiums; Premium four weeks and one day before deal announcement.

  • Long-range stock price trends for acquirers in selected acquisitions completed in 1992.  // Mergers & Acquisitions: The Dealermaker's Journal;Jan/Feb94, Vol. 28 Issue 4, p58 

    Presents the long-range stock price trends for acquirers in selected acquisitions completed in 1992. Seller; Target.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics